Wacker Chemie AG Logo

Wacker Chemie AG

WCH.DE

(3.5)
Stock Price

85,16 EUR

13.61% ROA

7.07% ROE

3.98x PER

Market Cap.

4.977.733.897,00 EUR

27.56% DER

11.98% Yield

4.9% NPM

Wacker Chemie AG Stock Analysis

Wacker Chemie AG Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Wacker Chemie AG Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (31.74%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

3 DER

The stock has a minimal amount of debt (28%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Dividend

The company's consistent dividend distribution over the past five years reflects its dedication to providing shareholders with steady returns, making it an appealing choice for investors seeking income stability.

5 PBV

The stock's PBV ratio (1.23x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

6 Revenue Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

7 Net Profit Growth

With continuous net profit growth in the past three years, this company demonstrates a strong financial performance, making it an enticing investment opportunity.

8 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

9 Dividend Growth

With a history of consistent dividend increases over the last three years, the company has proven to be a reliable choice for investors seeking reliable income.

10 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (585), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

11 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

Wacker Chemie AG Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Wacker Chemie AG Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Wacker Chemie AG Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Wacker Chemie AG Revenue
Year Revenue Growth
2004 2.504.300.000
2005 2.755.700.000 9.12%
2006 3.336.900.000 17.42%
2007 3.781.300.000 11.75%
2008 4.298.100.000 12.02%
2009 3.719.300.000 -15.56%
2010 4.748.400.000 21.67%
2011 4.909.700.000 3.29%
2012 4.634.900.000 -5.93%
2013 4.478.900.000 -3.48%
2014 4.826.400.000 7.2%
2015 5.296.200.000 8.87%
2016 5.404.200.000 2%
2017 4.924.200.000 -9.75%
2018 4.978.800.000 1.1%
2019 4.622.000.000 -7.72%
2020 4.692.200.000 1.5%
2021 6.207.500.000 24.41%
2022 8.209.300.000 24.38%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Wacker Chemie AG Research and Development Expenses
Year Research and Development Expenses Growth
2004 -150.600.000
2005 -146.900.000 -2.52%
2006 -152.300.000 3.55%
2007 -152.500.000 0.13%
2008 163.200.000 193.44%
2009 164.000.000 0.49%
2010 165.100.000 0.67%
2011 172.900.000 4.51%
2012 174.500.000 0.92%
2013 173.800.000 -0.4%
2014 183.100.000 5.08%
2015 175.300.000 -4.45%
2016 183.400.000 4.42%
2017 153.100.000 -19.79%
2018 164.600.000 6.99%
2019 153.600.000 -7.16%
2020 156.600.000 1.92%
2021 164.200.000 4.63%
2022 178.400.000 7.96%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Wacker Chemie AG General and Administrative Expenses
Year General and Administrative Expenses Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 109.500.000 100%
2009 95.500.000 -14.66%
2010 113.300.000 15.71%
2011 124.000.000 8.63%
2012 119.200.000 -4.03%
2013 111.700.000 -6.71%
2014 123.700.000 9.7%
2015 134.000.000 7.69%
2016 147.300.000 9.03%
2017 148.500.000 0.81%
2018 159.700.000 7.01%
2019 130.800.000 -22.09%
2020 139.500.000 6.24%
2021 158.800.000 12.15%
2022 183.200.000 13.32%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Wacker Chemie AG EBITDA
Year EBITDA Growth
2004 2.683.000.000
2005 2.815.300.000 4.7%
2006 3.084.200.000 8.72%
2007 3.367.200.000 8.4%
2008 1.055.200.000 -219.11%
2009 734.000.000 -43.76%
2010 1.171.300.000 37.33%
2011 1.081.900.000 -8.26%
2012 809.200.000 -33.7%
2013 729.500.000 -10.93%
2014 1.074.100.000 32.08%
2015 1.059.000.000 -1.43%
2016 1.085.800.000 2.47%
2017 1.004.300.000 -8.12%
2018 925.100.000 -8.56%
2019 739.600.000 -25.08%
2020 721.900.000 -2.45%
2021 1.527.400.000 52.74%
2022 2.043.800.000 25.27%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Wacker Chemie AG Gross Profit
Year Gross Profit Growth
2004 4.486.600.000
2005 4.861.700.000 7.72%
2006 5.714.900.000 14.93%
2007 6.410.600.000 10.85%
2008 1.188.000.000 -439.61%
2009 843.500.000 -40.84%
2010 1.346.300.000 37.35%
2011 1.162.500.000 -15.81%
2012 813.100.000 -42.97%
2013 663.500.000 -22.55%
2014 844.200.000 21.4%
2015 1.129.100.000 25.23%
2016 990.700.000 -13.97%
2017 954.400.000 -3.8%
2018 874.700.000 -9.11%
2019 727.600.000 -20.22%
2020 869.900.000 16.36%
2021 1.672.500.000 47.99%
2022 2.160.800.000 22.6%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Wacker Chemie AG Net Profit
Year Net Profit Growth
2004 16.100.000
2005 143.700.000 88.8%
2006 311.300.000 53.84%
2007 422.000.000 26.23%
2008 438.300.000 3.72%
2009 -74.500.000 688.32%
2010 497.000.000 114.99%
2011 356.100.000 -39.57%
2012 112.800.000 -215.69%
2013 2.600.000 -4238.46%
2014 203.800.000 98.72%
2015 246.700.000 17.39%
2016 179.200.000 -37.67%
2017 866.700.000 79.32%
2018 246.100.000 -252.17%
2019 -2.990.400.000 108.23%
2020 189.200.000 1680.55%
2021 806.900.000 76.55%
2022 1.251.000.000 35.5%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Wacker Chemie AG Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2004 53
2005 3 -2550%
2006 6 66.67%
2007 8 25%
2008 9 0%
2009 -2 900%
2010 10 111.11%
2011 7 -28.57%
2012 2 -250%
2013 0 0%
2014 4 100%
2015 5 0%
2016 4 -33.33%
2017 17 82.35%
2018 5 -325%
2019 -60 106.67%
2020 4 2100%
2021 16 81.25%
2022 25 36%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Wacker Chemie AG Free Cashflow
Year Free Cashflow Growth
2004 367.400.000
2005 455.800.000 19.39%
2006 761.100.000 40.11%
2007 1.322.500.000 42.45%
2008 258.300.000 -412%
2009 -3.000.000 8710%
2010 485.800.000 100.62%
2011 85.900.000 -465.54%
2012 -579.700.000 114.82%
2013 -103.100.000 -462.27%
2014 -39.900.000 -158.4%
2015 -203.500.000 80.39%
2016 222.200.000 191.58%
2017 328.900.000 32.44%
2018 100.800.000 -226.29%
2019 205.500.000 50.95%
2020 647.200.000 68.25%
2021 743.100.000 12.91%
2022 564.300.000 -31.69%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Wacker Chemie AG Operating Cashflow
Year Operating Cashflow Growth
2004 367.400.000
2005 455.800.000 19.39%
2006 761.100.000 40.11%
2007 1.322.500.000 42.45%
2008 1.005.400.000 -31.54%
2009 767.500.000 -31%
2010 1.103.100.000 30.42%
2011 867.000.000 -27.23%
2012 363.200.000 -138.71%
2013 464.000.000 21.72%
2014 485.200.000 4.37%
2015 617.200.000 21.39%
2016 736.600.000 16.21%
2017 657.100.000 -12.1%
2018 509.600.000 -28.94%
2019 205.500.000 -147.98%
2020 873.700.000 76.48%
2021 1.064.400.000 17.92%
2022 1.125.500.000 5.43%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Wacker Chemie AG Capital Expenditure
Year Capital Expenditure Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 747.100.000 100%
2009 770.500.000 3.04%
2010 617.300.000 -24.82%
2011 781.100.000 20.97%
2012 942.900.000 17.16%
2013 567.100.000 -66.27%
2014 525.100.000 -8%
2015 820.700.000 36.02%
2016 514.400.000 -59.55%
2017 328.200.000 -56.73%
2018 408.800.000 19.72%
2019 0 0%
2020 226.500.000 100%
2021 321.300.000 29.51%
2022 561.200.000 42.75%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Wacker Chemie AG Equity
Year Equity Growth
2004 909.200.000
2005 931.100.000 2.35%
2006 1.569.900.000 40.69%
2007 1.850.300.000 15.15%
2008 2.054.000.000 9.92%
2009 1.925.500.000 -6.67%
2010 2.422.100.000 20.5%
2011 2.603.400.000 6.96%
2012 2.599.600.000 -0.15%
2013 2.178.800.000 -19.31%
2014 1.922.400.000 -13.34%
2015 2.568.200.000 25.15%
2016 2.379.400.000 -7.93%
2017 3.119.200.000 23.72%
2018 3.145.500.000 0.84%
2019 2.029.000.000 -55.03%
2020 1.691.800.000 -19.93%
2021 3.100.400.000 45.43%
2022 5.030.700.000 38.37%
2023 4.611.700.000 -9.09%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Wacker Chemie AG Assets
Year Assets Growth
2004 2.815.399.936
2005 2.922.899.968 3.68%
2006 3.258.200.064 10.29%
2007 3.918.099.968 16.84%
2008 4.625.100.000 15.29%
2009 4.541.900.000 -1.83%
2010 5.501.200.000 17.44%
2011 6.237.000.000 11.8%
2012 6.329.900.000 1.47%
2013 6.332.400.000 0.04%
2014 6.947.200.000 8.85%
2015 7.264.400.000 4.37%
2016 7.461.600.000 2.64%
2017 6.835.700.000 -9.16%
2018 7.118.700.000 3.98%
2019 6.491.000.000 -9.67%
2020 6.950.500.000 6.61%
2021 8.134.300.000 14.55%
2022 9.401.400.000 13.48%
2023 8.712.300.000 -7.91%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Wacker Chemie AG Liabilities
Year Liabilities Growth
2004 1.906.199.936
2005 1.991.799.968 4.3%
2006 1.688.300.064 -17.98%
2007 2.067.799.968 18.35%
2008 2.542.300.000 18.66%
2009 2.599.500.000 2.2%
2010 3.054.400.000 14.89%
2011 3.607.300.000 15.33%
2012 3.712.100.000 2.82%
2013 4.135.300.000 10.23%
2014 5.000.700.000 17.31%
2015 4.469.300.000 -11.89%
2016 4.868.400.000 8.2%
2017 3.666.400.000 -32.78%
2018 3.973.200.000 7.72%
2019 4.462.000.000 10.95%
2020 5.258.700.000 15.15%
2021 5.033.900.000 -4.47%
2022 4.370.700.000 -15.17%
2023 4.100.600.000 -6.59%

Wacker Chemie AG Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
165.25
Net Income per Share
25.18
Price to Earning Ratio
3.98x
Price To Sales Ratio
0.61x
POCF Ratio
4.42
PFCF Ratio
8.82
Price to Book Ratio
1.02
EV to Sales
0.66
EV Over EBITDA
2.65
EV to Operating CashFlow
4.82
EV to FreeCashFlow
9.61
Earnings Yield
0.25
FreeCashFlow Yield
0.11
Market Cap
4,98 Bil.
Enterprise Value
5,42 Bil.
Graham Number
235.53
Graham NetNet
-17.31

Income Statement Metrics

Net Income per Share
25.18
Income Quality
0.88
ROE
0.32
Return On Assets
0.03
Return On Capital Employed
0.05
Net Income per EBT
0.93
EBT Per Ebit
0.88
Ebit per Revenue
0.06
Effective Tax Rate
0.18

Margins

Sales, General, & Administrative to Revenue
0.02
Research & Developement to Revenue
0.02
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.17
Operating Profit Margin
0.06
Pretax Profit Margin
0.05
Net Profit Margin
0.05

Dividends

Dividend Yield
0.12
Dividend Yield %
11.98
Payout Ratio
0.32
Dividend Per Share
12

Operating Metrics

Operating Cashflow per Share
22.66
Free CashFlow per Share
11.36
Capex to Operating CashFlow
-0.5
Capex to Revenue
-0.07
Capex to Depreciation
-1.4
Return on Invested Capital
0.18
Return on Tangible Assets
0.14
Days Sales Outstanding
53.75
Days Payables Outstanding
53.44
Days of Inventory on Hand
99.92
Receivables Turnover
6.79
Payables Turnover
6.83
Inventory Turnover
3.65
Capex per Share
-11.3

Balance Sheet

Cash per Share
35,75
Book Value per Share
97,91
Tangible Book Value per Share
96.98
Shareholders Equity per Share
97.91
Interest Debt per Share
28.02
Debt to Equity
0.28
Debt to Assets
0.14
Net Debt to EBITDA
0.22
Current Ratio
2.42
Tangible Asset Value
4,82 Bil.
Net Current Asset Value
0,29 Bil.
Invested Capital
0.28
Working Capital
2,73 Bil.
Intangibles to Total Assets
0.02
Average Receivables
1,10 Bil.
Average Payables
0,82 Bil.
Average Inventory
1416400000
Debt to Market Cap
0.27

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Wacker Chemie AG Dividends
Year Dividends Growth
2007 1
2008 1 0%
2009 2 100%
2010 1 0%
2011 3 66.67%
2012 2 -50%
2013 1 0%
2014 1 0%
2015 2 100%
2016 2 50%
2017 2 0%
2018 2 0%
2019 3 0%
2020 3 33.33%
2021 2 -50%
2022 8 75%
2023 12 33.33%

Wacker Chemie AG Profile

About Wacker Chemie AG

Wacker Chemie AG, together with its subsidiaries, provides chemical products worldwide. It operates through four divisions: Wacker Silicones, Wacker Polymers, Wacker Biosolutions, and Wacker Polysilicon. The Wacker Silicones division offers silanes, siloxanes, silicone fluids, silicone emulsions, silicone elastomers, silicone resins, and pyrogenic silicas for use in construction, electronics, automotive, health, and renewable energy industries. The Wacker Polymers division provides binders and polymeric additives, such as dispersible polymer powder and vinyl acetate-ethylene dispersions, which are used in construction, paper, adhesive, paint, coating, and basic chemical industries. The Wacker Biosolutions division offers customized biotech and catalog products for fine chemicals, such as pharmaceutical proteins, vaccines, cyclodextrins, cysteine, polyvinyl acetate solid resins, and acetylacetone for pharmaceutical actives, food additives, and agrochemicals. The Wacker Polysilicon division produces hyperpure polysilicon for use in semiconductor and solar sectors. The company was founded in 1914 and is headquartered in Munich, Germany. Wacker Chemie AG is a subsidiary of Dr. Alexander Wacker Familiengesellschaft mbH.

CEO
Dr. Christian Hartel
Employee
16.378
Address
Hanns-Seidel-Platz 4
Munich, 81737

Wacker Chemie AG Executives & BODs

Wacker Chemie AG Executives & BODs
# Name Age
1 Mr. Goetz Neumann
Head of Legal Affairs
70
2 Dr. Christian Hartel
Chief Executive Officer, President & Member of Executive Board
70
3 Mr. Jörg Hettmann
Head of Corporate Communications
70
4 Ms. Angela Worl
Head of Human Resource, Personnel Director & Member of Executive Board
70
5 Dr. Christian Kirsten
Member of the Executive Board
70
6 Mr. Rainald Hagenhues
Head of Corproate Accounting & Tax
70
7 Dr. Fridolin Stary
Head of Corporate Research & Development
70
8 Dr. Thomas Koini
Head of Sales & Distribution
70
9 Dr. Tobias Ohler
Chief Financial Officer & Member of the Executive Board
70
10 Mr. Joerg Hoffmann C.F.A.
Head of Investor Relations
70

Wacker Chemie AG Competitors

Symrise AG Logo
Symrise AG

SY1.DE

(2.5)
K+S Aktiengesellschaft Logo
K+S Aktiengesellschaft

SDF.DE

(2.5)
Aurubis AG Logo
Aurubis AG

NDA.DE

(2.5)
Evonik Industries AG Logo
Evonik Industries AG

EVK.DE

(1.5)